|
LOC202181 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.02539984783812E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.01139996377952E-09 |
| Normal-vs-Stage2 |
3.92169996477065E-09 |
| Normal-vs-Stage3 |
2.73470135425669E-11 |
| Normal-vs-Stage4 |
6.84959977625965E-10 |
| Stage1-vs-Stage2 |
4.766800E-01 |
| Stage1-vs-Stage3 |
4.571700E-02 |
| Stage1-vs-Stage4 |
4.130800E-01 |
| Stage2-vs-Stage3 |
5.008800E-01 |
| Stage2-vs-Stage4 |
9.573400E-01 |
| Stage3-vs-Stage4 |
5.074800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.48529974378187E-10 |
| Normal-vs-AfricanAmerican |
3.615100E-04 |
| Normal-vs-Asian |
5.0113999616741E-09 |
| Caucasian-vs-AfricanAmerican |
3.522400E-01 |
| Caucasian-vs-Asian |
7.550600E-01 |
| AfricanAmerican-vs-Asian |
4.794600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.7752002352297E-10 |
| Normal-vs-Female |
2.054699743681E-10 |
| Male-vs-Female |
9.008000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.83369996964444E-09 |
| Normal-vs-Age(41-60Yrs) |
4.42969994018938E-10 |
| Normal-vs-Age(61-80Yrs) |
1.79130044131171E-11 |
| Normal-vs-Age(81-100Yrs) |
6.69519999996204E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.637000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.940300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.747400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.338840E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.583000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.757000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.317570E-02 |
| Classical-VS-Follicular |
2.125800E-01 |
| Classical-VS-Other |
5.565600E-01 |
| Classical-VS-Normal |
2.54660004195273E-09 |
| Tall-VS-Follicular |
2.824000E-01 |
| Tall-VS-Other |
7.798600E-01 |
| Tall-VS-Normal |
4.00579569515003E-11 |
| Follicular-VS-Other |
9.238200E-01 |
| Follicular-VS-Normal |
6.42000008710397E-10 |
| Other-VS-Normal |
5.023300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.54440024605174E-10 |
| Normal-vs-N1 |
4.11180000048361E-08 |
| N0-vs-N1 |
4.811200E-01 |
|
|
